MilliporeSigma has acquired Wilbraham, MA-based FloDesign Sonics, a developer of an acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing.   “Chimeric antigen receptor T cell therapies, or CAR-T for short, employs the body’s own immune systems to fight cancer by turning T cells into targeted therapeutics. This revolutionary cancer treatment is challenging and complex, with the process often taking up to a month,” said Udit Batra, chief executive offic...